Diametric Capital, LP Sellas Life Sciences Group, Inc. Transaction History
Diametric Capital, LP
- $173 Million
- Q3 2024
A detailed history of Diametric Capital, LP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Diametric Capital, LP holds 160,194 shares of SLS stock, worth $237,087. This represents 0.12% of its overall portfolio holdings.
Number of Shares
160,194
Previous 153,019
4.69%
Holding current value
$237,087
Previous $182,000
9.89%
% of portfolio
0.12%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding SLS
# of Institutions
38Shares Held
5.69MCall Options Held
1.67MPut Options Held
74.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$3.39 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX794KShares$1.17 Million0.12% of portfolio
-
Geode Capital Management, LLC Boston, MA605KShares$895,6820.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$636,9440.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$456,5293.71% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $30.4M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...